CoChat

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Open access
Charleer, Sara, Mathieu, Chantal, Nobels, Frank, De Block, Christophe, Radermecker, Regis P, Hermans, Michel P, Taes, Youri, Vercammen, Chris, T'Sjoen, Guy, Crenier, Laurent, Fieuws, Steffen, Keymeulen, Bart, Gillard, Pieter, RESCUE Trial Investigators · 2018 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

Abstract

Context: Randomized controlled trials evaluating real-time continuous glucose monitoring (RT-CGM) patients with type 1 diabetes (T1D) show improved glycemic control, but limited data are available on real-world use. Objective: To assess impact of RT-CGM in real-world settings on glycemic control, hospital admissions, work absenteeism, and quality of life (QOL). Design: Prospective, observational, multicenter, cohort study. Participants: A total of 515 adults with T1D on continuous subcutaneous insulin infusion (CSII) therapy starting in the Belgian RT-CGM reimbursement program. Intervention: Initiation of RT-CGM reimbursement. Main Outcome Measure: Hemoglobin A1c (HbA1c) evolution from baseline to 12 months. Results: Between September 1, 2014, and December 31, 2016, 515 adults entered the reimbursement system. Over this period, 417 (81%) patients used RT-CGM for at least 12 months. Baseline HbA1c was 7.7 ± 0.9% (61 ± 9.8 mmol/mol) and decreased to 7.4 ± 0.8% (57 ± 8.7 mmol/mol) at 12 months (P < 0.0001). Subjects who started RT-CGM because of insufficient glycemic control showed stronger decrease in HbA1c at 4, 8, and 12 months compared with patients who started because of hypoglycemia or pregnancy. In the year preceding reimbursement, 16% of patients were hospitalized for severe hypoglycemia or ketoacidosis in contrast to 4% (P < 0.0005) the following year, with decrease in admission days from 54 to 18 per 100 patient years (P < 0.0005). In the same period, work absenteeism decreased and QOL improved significantly, with strong decline in fear of hypoglycemia. Conclusion: Sensor-augmented pump therapy in patients with T1D followed in specialized centers improves HbA1c, fear of hypoglycemia, and QOL, whereas work absenteeism and admissions for acute diabetes complications decreased.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2017-02498

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 1

  1. Ware, 1993, SF-36 Health Survey: Manual and Interpretation Guide

Cited by

Metadata

Authors
Charleer, S., Mathieu, C., Nobels, F., De Block, C., Radermecker, R. P., Hermans, M. P., Taes, Y., Vercammen, C., T'Sjoen, G., Crenier, L., Fieuws, S., Keymeulen, B., Gillard, P., & RESCUE Trial Investigators
Affiliations
  • Research Foundation - Flanders (BE)
  • KU Leuven (BE)
  • Onze Lieve Vrouwziekenhuis Hospital (BE)
  • Department of Endocrinology, Diabetology and Metabolism, University of Antwerp–Antwerp University Hospital, Antwerp, Belgium
  • Department of Diabetes, Nutrition and Metabolic Disorders, Centre Hospitalier Universitaire Liege–Liege University, Liege, Belgium
  • Cliniques Universitaires Saint-Luc (BE)
  • AZ Sint-Jan (BE)
  • Imelda Hospital (BE)
  • Ghent University Hospital (BE)
  • Université Libre de Bruxelles (BE)
  • Hasselt University (BE)
  • Vrije Universiteit Brussel (BE)
Corresponding author
Gillard, Pieter
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2018-01-12
Volume
103
Issue
3
Pages
1224-1232
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2791573153
Cited by
196
References
29
Citations by year
2026: 14 · 2025: 23 · 2024: 23 · 2023: 22 · 2022: 27 · 2021: 39 · 2020: 15 · 2019: 22 · 2018: 11
FWCI
17.31
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • Lirias (submittedVersion, other-oa)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Digital Access to Libraries (submittedVersion, other-oa)
  • Document Server@UHasselt (UHasselt) (submittedVersion)
  • ORBi (University of Liège) (submittedVersion, other-oa)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders
  • Fonds Wetenschappelijk Onderzoek (10.13039/501100003130, http://dx.doi.org/10.13039/501100003130, 1S13517N, 501100003130)
  • Vlaamse regering
  • Horizon 2020 Framework Programme
  • Universitaire Ziekenhuizen Leuven, KU Leuven
  • H2020 European Institute of Innovation and Technology (http://dx.doi.org/10.13039/100010686)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
continuous glucose monitoring, type 1 diabetes, glycemic control, HbA1c, hospitalization, absenteeism, quality of life, fear of hypoglycemia, insulin pump therapy, sensor-augmented pump therapy, hypoglycemia, diabetic ketoacidosis
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Hospitalization, Humans, Hypoglycemia, Male, Middle Aged, Prospective Studies, Quality of Life, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.